Cytokine enhancement of immunogenicity in chronic myeloid leukaemia

Leukemia

Volumn 11, Issue 12, 1997, Pages 2055-2059

  Coleman, S ^a   Throp, D ^a   Fisher, J ^a   Bailey Wood, R ^a   Lim, S H ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

CML; Costimulatory molecules; Immunogenicity

Indexed keywords

B7 ANTIGEN; CD1 ANTIGEN; CD86 ANTIGEN; CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 4;

ARTICLE; CANCER IMMUNOLOGY; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOGENICITY; LEUKEMIA CELL; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0031434677     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2400858     Document Type: Article

References (16)

1. Marmont AM, Horowitz MM, Gale RP, Sobocinski K, Ash RC, van Bekkum DW, Champlin RE, Dicke KA, Goldman JM, Good RA, Herzig RH, Hong R, Masaoka T, Rimm AA, Ringden O, Speck B, Weiner RS, Bortin MM. T cell depletion of HLA-identical transplants in leukemia, Blood 1991; 78: 2120-2130.
2. Hale G, Waldman H. Control of graft-versus-host disease and graft rejection by T cell depletion of donor and recipient with CAM-PATH-1 antibodies. Results of matched sibling transplant for malignant disease. Bone Marrow Transplant 1994; 13: 597-611.
3. Kolb HJ, Mitteruller J, Clemm C, Holler E, Ledderose C, Brehm G, Heim M, Wilmanns W. Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood 1990; 76: 2462-2465.
4. Lim SH, Coleman S. Chronic myeloid leukemia as an immunological target. Am J Hematol 1997; 54: 61-67.
5. Coleman S, Perera P, Fisher J, Hoy T, Burnett AK, Lim SH. Abnormal TCR V repertoire in patients with chronic myeloid leukaemia. Br J Haematol 1995; 90: 358-361.
6. Coleman S, Fisher J, Hoy T, Burnett AK, Lim SH. Autologous MHC-dependent leukaemia-reactive T lymphocytes in a patient with chronic myeloid leukaemia. Leukemia 1996; 10; 483-487.
7. Lim SH, Coleman S, Bull A, O'Callaghan U, Evely R, Booth M. Cyclosporin A/alpha interferon-induced autologous graft-versushost disease following peripheral blood stem cell transplant for chronic myeloid leukaemia: a clinico-pathological study. Bone Marrow Transplant 1997; 20: 83-85.
8. + T cells by B7-transfected melanoma cells. Science 1993; 259: 368-370.
9. Dunussi-Joannopoulos K, Weinstein HJ, Nickerson PW, Strom TB, Burakoff SJ, Croop JM, Arceci RJ. Irradiated B7-1 transduced primary acute myelogenous leukemia (AML) cell can be used as therapeutic vaccines in murine AML. Blood 1996; 87:2938-2946.
10. Lundberg A, Gribben J, Lazo S, Nadler L. Expression and induction of B7 on leukemic cells isolated from patients with hematologic malignancies. Blood 1993; 82 (Suppl.): 123a.
11. Romani N, Gruner S, Brang D, Kampgen E, Lenz A, Trockenbacher B, Konwalinka G, Fritsch PO, Steinman RM, Schuler G. Proliferating dendritic cell progenitor in human blood, J Exp Med 1994; 180: 83-93.
12. Smith WM, Rijnbeek M, van Bergen CAM, de Paus RA, Vervenne HAW, van de Keur M, Willemze R, Falkenburg JHF. Generation of dendritic celfs expressing bcr-abl from CD34-positive chronic myeloid leukemia precursor cells. Hum Immunol 1997; 53: 216-223.
13. Choudhury A, Gajewski JL, Liang JC, Popat U, Claxton DF, Kliche KO, Andreef M, Champlin RE. Use of leukemic dendritic cells for the generation of antileukemic cellular cytotoxicity against Philadelphia chromosome-positive chronic myelogenous leukemia. Blood 1997; 89: 1133-1142.
14. Greco G, Fruci D, Accapezzato D, Barnaba V, Nisini R, Alimena G, Montefusco E, Vigneti R, Tanigaki N, Tosi R. Two bcr-abl peptides bind HLA-A3 molecules and allow specific induction of human cytotoxic T lymphocytes. Leukemia 1996; 10: 693-699.
15. BCR-ABL protein by human T cells. Leukemia 1995; 9: 1344-1348.
16. Pawelec G, Max H, Halder T, Bruserud Ø, Merl A, da Silva P, Kalbacher H. BCR-ABL leukemia oncogene fusion peptides selectively bind to certain HLA-DR alleles and can be recognised by T cells found at low frequency in the repertoire of normal donors. Blood 1996; 88: 2118-2124.